Chudzicka-Czupała, Agata
Chiang, Soon-Kiat
Tan, Clara M.
Hapon, Nadiya
Żywiołek-Szeja, Marta
Karamushka, Liudmyla
Paliga, Mateusz
Dubniak, Zlatyslav
McIntyre, Roger S.
Ho, Roger
Funding for this research was provided by:
Fundacja na rzecz Nauki Polskiej
Article History
Received: 16 June 2023
Accepted: 19 November 2023
First Online: 25 November 2023
Competing interests
: Dr. Roger McIntyre has received research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC) and the Milken Institute; speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Abbvie, Atai Life Sciences. Dr. Roger McIntyre is a CEO of Braxia Scientific Corp. The other authors have no conflict of interest. Dr Roger Ho receives funding in NUS iHealthtech Other Operating Expenses (A-0001415-09-00).